Loading...
Loading...
India's celecoxib imports from JAPAN total $978 across 2 shipments from 1 foreign suppliers. TEVA TAKEDA PHARMA LTD. leads with $978 in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include CHOKSI LABORATORIES LIMITED. This corridor reflects India's pharmaceutical import demand for celecoxib — a concentrated sourcing relationship with select suppliers from JAPAN.

TEVA TAKEDA PHARMA LTD. is the leading Celecoxib supplier from JAPAN to India, with import value of $978 across 2 shipments. The top 5 suppliers — TEVA TAKEDA PHARMA LTD. — collectively account for 100.0% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | TEVA TAKEDA PHARMA LTD. | $978 | 2 | 100.0% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | CHOKSI LABORATORIES LIMITED | $978 | 2 | 100.0% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Celecoxib suppliers from JAPAN to India include TEVA TAKEDA PHARMA LTD.. The leading supplier is TEVA TAKEDA PHARMA LTD. with import value of $978 USD across 2 shipments. India imported Celecoxib worth $978 USD from JAPAN in total across 2 shipments.
India imported Celecoxib worth $978 USD from JAPAN across 2 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Celecoxib sourced from JAPAN include CHOKSI LABORATORIES LIMITED. The largest buyer is CHOKSI LABORATORIES LIMITED with $978 in imports across 2 shipments.
The total value of Celecoxib imports from JAPAN to India is $978 USD, across 2 shipments and 1 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
2 Verified Shipments
1 suppliers, 1 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists